Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08AAV
|
||||
Former ID |
DIB004590
|
||||
Drug Name |
AZD-3514
|
||||
Indication | Hormone refractory prostate cancer [ICD9: 140-229, 185; ICD10:C61] | Phase 1 | [523468] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Antagonist | [532431] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.